Health

Novo-backed surgical robot maker Procept will fund recruitment and product development initiatives with the proceeds of an IPO for which it has just set terms.

Existing backer Novo has helped the teeth straightening technology producer close a series D round hiking its overall funding to over $170m.

SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.

The Aviva and Foxconn-backed respiratory system developer beat the target for its series D round to bring its total funding to over $150m.

Alphabet subsidiary Verily is set to exit Ciitizen, a management software platform for healthcare data, after Invitae agreed to buy the company.

Stryker has bought the surgery monitoring software provider, which was backed by SoftBank and multiple healthcare providers.

Home rental finance service Jetty bagged $23m from investors including Citi, Farmers Insurance and CreditEase, while ByteDance co-led IoT technology developer RiVai's latest round.

LabCorp and Cedars-Sinai-backed Emulate will use the cash to further develop its organ-on-a-chip technology and has now raised nearly $225m in total.

Kyoritsu Holding and Tencent were among the investors that backed the pet antibody therapeutics developer, a spinout of Wellcome Sanger Institute.

Channel Talk, Segari and Borneo are all among the companies that have raised corporate venture capital, while Tepco celebrated an exit with the acquisition of Me:New.

SoftBank-backed cancer immunotherapy developer ICT has collected series C funding from CDH Investments’ CDH VGC unit.